![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 14/605 | (2006.01) |
A61K 38/26 | (2006.01) | ||
A61K 38/28 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 31/137 | (2006.01) | ||
A61K 31/155 | (2006.01) | ||
A61K 31/198 | (2006.01) | ||
A61K 31/485 | (2006.01) | ||
A61K 31/7048 | (2006.01) |
(11) | Number of the document | 3057984 |
(13) | Kind of document | T |
(96) | European patent application number | 14795564.5 |
Date of filing the European patent application | 2014-10-17 | |
(97) | Date of publication of the European application | 2016-08-24 |
(45) | Date of publication and mention of the grant of the patent | 2018-07-11 |
(46) | Date of publication of the claims translation | 2018-12-27 |
(86) | Number | PCT/EP2014/072293 |
Date | 2014-10-17 |
(87) | Number | WO 2015/055801 |
Date | 2015-04-23 |
(30) | Number | Date | Country code |
201361892256 P | 2013-10-17 | US |
(72) |
RIBER, Ditte, DK
TOLBORG, Jakob Lind, DK
HAMPRECHT, Dieter Wolfgang, DE
RIST, Wolfgang, DE
|
(73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
Zealand Pharma A/S, Smedeland 36, 2600 Glostrup, DK |
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Acilinti gliukagono analogai |
ACYLATED GLUCAGON ANALOGUES |
Payment date | Validity (years) | Amount | |
2024-09-24 | 11 | 289.00 EUR |
2025-10-17 |